Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/4/13 → 1/31/16 |
Funding
- Vertex Pharmaceuticals Inc: $82,158.00
VX12-809-105 A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lu,acaftor in Combination With Ivacaftor in
- Anstead, Michael (PI)